Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
January 20, 2015  

Research ShowCASE and Spring Intersections: Discovery, Collaboration & Community

Friday, April 17, 2015
9:00 am – 3:00 pm
Veale Convocation Center
Case Western Reserve University


The CWRU Office of Research and Technology Management and SOURCE (Support of Undergraduate Research and Creative Endeavors) are pleased to announce the opening of the Call for Presentations for Research ShowCASE 2015.

We invite you to participate with other CWRU faculty, staff and students by presenting your work at Research ShowCASE 2015. The event will provide an opportunity for you to display your research in a traditional scientific poster or other creative means. We encourage University Hospitals, Cleveland Clinic, MetroHealth Medical Center and the Louis Stokes Cleveland VA Medical Center researchers to participate.

In addition to the opportunity to display and share your work, undergraduate and graduate students, professional students and postdoctoral scholars are encouraged to participate in the research competition, which will include having your presentation evaluated and feedback provided. Prizes will be awarded to winning entries.

In order to display your work at Research ShowCASE, you will need to submit an online abstract describing your research. If you are a student or post-doc, your faculty advisor will need to approve your submission.

New this year:

  • You will need to provide a brief description of your research in non-scientific terms
  • You will be given the opportunity to provide a video abstract of your work in addition to the written abstract
  • If you provide a 140-character title or description of your entry, we will tweet about your work
Abstract Submission Deadline: February 15, 2015 (for graduate students, post-docs, professional students, faculty and staff)

Undergraduate submissions will be accepted between February 16, 2015 and March 20, 2015.

Find out more and submit your abstract at: showCASE.case.edu.

 
Limited Submission Reminder: NIH Outstanding New Environmental Scientist Award

Key Deadlines: December 5, 2014, 5:00pm (CWRU Letter of Intent), January 27, 2015, 5:00pm EST (agency Letter of Intent), February 27, 2015, 5:00pm EST (agency application).

An essential element of the mission of the National Institute of Environmental Health Sciences (NIEHS) is the support and career promotion of the next generation of exceptionally talented and creative new scientists who will further the understanding of the impact of environmental exposures on human health. The NIEHS supports a number of training and fellowship programs for pre and postdoctoral training, and mentored career development awards for faculty in the early stages of their career development. Along with these training and career development programs, NIEHS initiated a program of research grants for Early Stage Investigators, The Outstanding New Environmental Scientist (ONES) Award, that is designed to identify the best new biomedical investigators across the spectrum of science supported by the NIEHS (i.e., including basic mechanistic, clinical and population based researchers) and facilitate their establishing a vibrant, independent research program in the environmental health sciences. NIEHS uses this FOA to support the NIEHS goal of assuring a continuing cadre of productive environmental health science investigators.

Number of Applications Allowed: Only one application per School or College within a University will be accepted.

Amount of Funding: For most applications, the budget for direct costs should be limited to $250,000 per year, plus the portion of the additional $250,000 budget for career enhancement which will be distributed over a 5-year award period. Note: the $250,000 career enhancement budget will be distributed over a 5-year period but does not have to be distributed evenly across each year. With strong justification, research projects which have inherently higher costs may request direct costs of up to $400,000 per year, plus career enhancement. In no year may the total direct cost budget (research plus career enhancement) exceed $475,000 per year.

For more information on this limited submission opportunity, visit the Office of Research Administration website.

 
NIH Center for Accelerated Innovation at Cleveland Clinic (NCAI-CC)

The NIH Center for Accelerated Innovation at Cleveland Clinic (NCAI-CC) Announces the Request for Applications (RFA) for the third funding cycle.

Funding is available for promising emerging technologies directed towards diagnosis, treatment or management of cardiovascular, pulmonary, blood or sleep-related disorders. NCAI-CC is seeking projects such as therapeutics (e.g. drugs, biologics), preventatives, diagnostics, devices, tools, etc., in order to facilitate their translation to commercialized products that improve patient care and enhance health. The NCAI-CC will provide funding and project assistance to advance the development of high priority early-stage technologies within the mission areas of the NHLBI (cardiovascular, lung, blood and sleep disorders). Expert assistance will be provided in areas required for early technology development, including commercial opportunity assessment, intellectual property, clinical and regulatory, reimbursement, business, legal and project management.

Eligibility: Investigators from the Cleveland Clinic, Case Western Reserve University, The Ohio State University,Cincinnati Children’s Hospital, and University of Cincinnati

Letter of Intent Deadline: February 10, 2015

For more information visit the NCAI-CC website.

 
Ohio Third Frontier (OTF), Ohio Development Services Agency

The goal of the Ohio Third Frontier Technology Validation and Start-Up Fund (TVSF) is to increase economic growth in Ohio through start-up companies that commercialize technologies developed by Ohio institutions of higher education and other Ohio not-for-profit research institutions. Two separate mechanisms have been set up to achieve these goals:

Phase 1 –Technology Validation The specific objectives of this phase are as follows:
• To generate the proof needed to move technology to the point that it is either ready to be licensed by an Ohio start-up company or otherwise deemed unfeasible for commercialization.
• To fund validation activities, such as prototyping, demonstrations, and assessment of critical failure points in subsequent development, scale-up, and commercialization.

Phase 2 – Start-Up Funds The specific objectives of this phase are as follows:
• To support Ohio start-up companies that have licensed technology developed at Ohio research institutions during the critical early life of the company, and accelerate the time to market of this technology.
• To generate the proof needed to either commercialize the technology or move the technology to the point where additional funds needed for commercialization can be raised.
• To fund activities in order to generate the needed proof.

The TVSF will support technology that falls within the following areas: Advanced Materials related to advanced polymers, ceramics, composites, carbon fibers and nanotubes and specialty metals and alloys; Aeropropulsion Power Management; Agribusiness and Food Processing; Fuel Cells and Energy Storage; Medical Technology related to imaging, surgical instruments/equipment, implant devices, and regenerative medicine; Software Applications for business and healthcare; Sensing and Automation Technologies; Situational Awareness and Surveillance Systems; Solar Photovoltaics; and Shale.

Potential CWRU Applicants - Contact:
Michael Haag, MS, MBA, Executive Director, Technology Management, 216-368-6106 or mhaag@case.edu.

For more information on the TVSF visit the Ohio Third Frontier website.

 
National Multiple Sclerosis Society

The Barancik Prize for Innovation in Multiple Sclerosis Research recognizes an exceptional scientist or a team of scientists whose work in MS research has demonstrated outstanding innovation and originality.

The prize is administered by the National Multiple Sclerosis Society. A selection committee comprised of leaders in science, medicine, and MS advocacy will review nominees. The committee will evaluate:
• Exceptional innovation and originality in scientific research relevant to MS
• Impact and potential of the research to lead to pathways for the treatment and cure for MS
• Scientific accomplishments that merit recognition as a future leader in MS research

For more information and guidelines , visit the Society’s website.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.